- Home
- RVTY vs BCH Comparison
RVTY vs BCH Comparison
Compare RVTY & BCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RVTY | BCH |
|---|---|---|
| Founded | 1937 | 1893 |
| Country | United States | Chile |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Commercial Banks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.0B | 19.7B |
| IPO Year | 1994 | 2002 |
Fundamental Metrics
Financial Performance| Metric | RVTY | BCH |
|---|---|---|
| Price | $156.64 | $36.71 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 18 | 12 |
| Target Price | ★ $147.53 | $40.94 |
| AVG Volume (30 Days) | ★ 1.5M | 358.8K |
| Earning Date | 11-03-2026 | 10-30-2026 |
| Dividend Yield | 0.17% | ★ 4.32% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.82 | N/A |
| Revenue | ★ $3,311,822,000.00 | N/A |
| Revenue This Year | N/A | $7.00 |
| Revenue Next Year | $5.44 | $7.53 |
| P/E Ratio | $201.73 | ★ $16.27 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $81.22 | $33.60 |
| 52 Week High | $169.06 | $46.77 |
Technical Indicators
Market Signals| Indicator | RVTY | BCH |
|---|---|---|
| Relative Strength Index (RSI) | 53.86 | 30.88 |
| Support Level | $146.70 | $36.66 |
| Resistance Level | $166.25 | $39.45 |
| Average True Range (ATR) | 5.87 | 0.82 |
| MACD | -0.26 | -0.08 |
| Stochastic Oscillator | 36.38 | 0.64 |
Price Performance
Historical ComparisonAbout RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
About BCH Banco De Chile ADS
Operating under three separate brand names (Banco de Chile, Banco Edwards-Citi, and Banco CrediChile), Banco de Chile is the second largest in the country by loans and third largest by deposits. Banco de Chile generates most of its net interest income (roughly 60% of total revenue) from its mortgage, unsecured consumer credit lines, and commercial loans, with 25% of its outstanding loans being made to firms with more than 10,000 million CLP in revenue. Outside of its banking business, Banco de Chile is the largest asset manager in the country and one of the largest security brokerages, supporting its substantial fee-based revenue.